Body mass index (BMI) does not predict responses to psilocybin

BACKGROUND: Psilocybin is a serotonin type 2A (5-HT(2A)) receptor agonist and naturally occurring psychedelic. 5-HT(2A) receptor density is known to be associated with body mass index (BMI), however, the impact of this on psilocybin therapy has not been explored. While body weight-adjusted dosing is...

Descripción completa

Detalles Bibliográficos
Autores principales: Spriggs, Meg J, Giribaldi, Bruna, Lyons, Taylor, Rosas, Fernando E, Kärtner, Laura S, Buchborn, Tobias, Douglass, Hannah M, Roseman, Leor, Timmermann, Christopher, Erritzoe, David, Nutt, David J, Carhart-Harris, Robin L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834321/
https://www.ncbi.nlm.nih.gov/pubmed/36373934
http://dx.doi.org/10.1177/02698811221131994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834321/
https://www.ncbi.nlm.nih.gov/pubmed/36373934
http://dx.doi.org/10.1177/02698811221131994

Ejemplares similares